Skip to content

Comparison of the Efficacy and Safety of Ciprofol versus Propofol for Sedation in ICU Patients Undergoing Non-Invasive Ventilation: A Multicenter Retrospective Cohort Study

Comparison of the Efficacy and Safety of Ciprofol versus Propofol for Sedation in ICU Patients Undergoing Non-Invasive Ventilation: A Multicenter Retrospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600130687
Enrollment
Unknown
Registered
2026-08-23
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypoxemia, anxiety, agitation, poor tolerance, and hypoxia-related discomfort

Interventions

Sponsors

Southern Medical University Southern Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. Admitted to the ICU for clinical management between January 2022 and July 2024; 3. Received intravenous sedation with ciprofol or propofol during the ICU stay, with a single or cumulative duration >= 2 hours (allowing cumulative interruptions <= 30 minutes); 4. Were undergoing non-invasive respiratory support at the initiation of sedation, including NIV, HFNC, or conventional nasal cannula/mask oxygen therapy; 5. Had complete and continuous electronic medical record documentation of the following: RASS scores; vital signs (respiratory rate, SpO2, blood pressure, heart rate, etc.); sedative medication regimen (dose, administration method, adjustment details); respiratory support mode and its changes over time.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Concurrent or prior use of other major sedatives, such as midazolam or dexmedetomidine; 3.Cumulative use of ciprofol or propofol 30% (including sedation depth [RASS scores], vital signs, medication records, etc.); 6.Patients who received invasive mechanical ventilation (endotracheal intubation) prior to enrollment or with unclear airway management records; 7.Participation in other interventional clinical trials that may interfere with the assessment of study outcomes; 8.Severe hearing or vision impairment, coma, altered consciousness, or other conditions that may significantly affect data collection and accurate RASS assessment; 9.Patients deemed unsuitable for participation by the investigators.

Design outcomes

Primary

MeasureTime frame
incidence of respiratory depression;sedation success rate;

Secondary

MeasureTime frame
ICU length of stay (ICU LOS);use of vasopressors;ICU mortality;overall intubation rate;

Countries

China

Contacts

Public ContactZhenhua Zeng

Southern Medical University Southern Hospital

zhenhuazeng.2008@163.com+86 15692428912

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026